Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Posaconazole pharmacokinetics in plasma and alveolar compartment after lung transplantation
2012-003140-68Phase 4Terminated
- Sponsor
- Merck & Co.
- Start
- Sep 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of posaconazole in invasive mycoses (2 cohorts), sponsored by Merck & Co. Primary endpoints: Time to reach steady-state plasma posaconazole level and Posaconazole alveolar compartment level and concurrent plasma level. Started Sep 2012; status: terminated.
02
Drugs
posaconazole
03
Conditions
invasive mycoses
Beyond the preview
Go deeper on 2012-003140-68.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-003140-68.